Danaher buying GE biopharma unit for $21.4B

General Electric Co. (NYSE:GE) agreed to sell its biopharma business for $21.4 billion in cash to Danaher Corp. (NYSE:DHR).

Danaher said the business unit will complement its biologics workflow solutions. The division includes products and solutions that facilitate research into fundamental cell and protein biology as well as the development and production of biologic drugs, vaccines and cell therapies...